Table 1.

Clinicopathologic characteristics.

Patient characteristics	No. (%)
All patients	16 (100)
Sex
Male	9 (56.2)
Female	7 (43.8)
Age
Median (range)	60 (35-73)
<50	3 (18.8)
50-59	5 (31.3)
60-69	6 (37.5)
70+	2 (12.5)
Therapy
SSA or FU	11 (68.7)
SSA + everolimus	2 (12.5)
Chemotherapy	3 (18.8)
Follow-up, y
Median (range)	3.8 (1.7-15.9)
Person-years	81
Deaths	6
Annual death rate	7.4/100 y

Abbreviations: FU, follow-up only; SSA, somatostatin analogues.